Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development

Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development

Submitted by admin on October 6, 2021 - 10:43am
Source: 
Biopharma Reporter
News Tags: 
Dynavax
Department of Defense
clinical trials
vaccines
pneumonic plague
Headline: 
Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development
snippet: 

Dynavax will conduct a Phase 2 clinical trial combining the US Department of Defense’ rF1V vaccine with its CpG 1018 adjuvant.

Do Not Allow Advertisers to Use My Personal information